Differences between CD95 type I and II cells detected with the CD95 ligand

Cell Death Differ. 1999 Sep;6(9):821-2. doi: 10.1038/sj.cdd.4400569.

Authors

I Schmitz¹, H Walczak, P H Krammer, M E Peter

Affiliation

¹ Tumor Immunology Program, German Cancer Research Center, Heidelberg, Germany. MPeter@ben-may.bsd.uchicago.edu

PMID: 10627164
DOI: 10.1038/sj.cdd.4400569

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Adaptor Proteins, Signal Transducing*
Apoptosis*
Carrier Proteins / metabolism
Cell Line
Fas Ligand Protein
Fas-Associated Death Domain Protein
Humans
Jurkat Cells
Membrane Glycoproteins / metabolism*
Proto-Oncogene Proteins c-bcl-2 / biosynthesis
Proto-Oncogene Proteins c-bcl-2 / genetics
Signal Transduction*
bcl-X Protein
fas Receptor / metabolism*

Substances

Adaptor Proteins, Signal Transducing
BCL2L1 protein, human
Carrier Proteins
FADD protein, human
FASLG protein, human
Fas Ligand Protein
Fas-Associated Death Domain Protein
Membrane Glycoproteins
Proto-Oncogene Proteins c-bcl-2
bcl-X Protein
fas Receptor